EC
Euclidean Capital’s Oric Pharmaceuticals ORIC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Hold |
989,410
| – | – | 3.28% | 3 |
|
|
2025
Q1 | $5.52M | Hold |
989,410
| – | – | 2.07% | 4 |
|
|
2024
Q4 | $7.98M | Hold |
989,410
| – | – | 1.08% | 4 |
|
|
2024
Q3 | $10.1M | Hold |
989,410
| – | – | 1.12% | 5 |
|
|
2024
Q2 | $7M | Hold |
989,410
| – | – | 0.88% | 4 |
|
|
2024
Q1 | $13.6M | Hold |
989,410
| – | – | 1.74% | 4 |
|
|
2023
Q4 | $9.1M | Hold |
989,410
| – | – | 1.02% | 8 |
|
|
2023
Q3 | $5.99M | Buy |
989,410
+241,860
| +32% | +$1.46M | 1.31% | 9 |
|
|
2023
Q2 | $5.8M | Hold |
747,550
| – | – | 1.49% | 9 |
|
|
2023
Q1 | $4.26M | Hold |
747,550
| – | – | 3.74% | 7 |
|
|
2022
Q4 | $4.4M | Hold |
747,550
| – | – | 4.12% | 7 |
|
|
2022
Q3 | $2.39M | Hold |
747,550
| – | – | 2.22% | 9 |
|
|
2022
Q2 | $3.35M | Hold |
747,550
| – | – | 2.85% | 9 |
|
|
2022
Q1 | $3.99M | Hold |
747,550
| – | – | 2.32% | 10 |
|
|
2021
Q4 | $11M | Sell |
747,550
-29,643
| -4% | -$436K | 6.25% | 7 |
|
|
2021
Q3 | $16.3M | Sell |
777,193
-219,541
| -22% | -$4.59M | 7.9% | 7 |
|
|
2021
Q2 | $17.6M | Hold |
996,734
| – | – | 5.72% | 7 |
|
|
2021
Q1 | $24.4M | Sell |
996,734
-403,701
| -29% | -$9.89M | 8.17% | 3 |
|
|
2020
Q4 | $47.4M | Buy |
+1,400,435
| New | +$47.4M | 10.04% | 3 |
|